---
agency: Department of Health and Human Services
applicant_types:
- Federal
- Government - General
- Individual/Family
- Interstate
- Local (includes State-designated lndian Tribes, excludes institutions of higher
  education and hospitals
- Minority group
- Non-Government - General
- Profit organization
- Public nonprofit institution/organization (includes institutions of higher education
  and hospitals)
- Specialized group (e.g. health professionals, students, veterans)
- Sponsored organization
- State
- State (includes District of Columbia, public institutions of higher education and
  hospitals)
- U.S. Territories and possessions
- U.S. Territories and possessions (includes institutions of higher education and
  hospitals)
assistance_types:
- Project Grants
authorizations:
- Pub. L. The United States Leadership Against HIV/AIDS, Tuberculosis and Malaria
  Act of 2003; The Tom Lantos and Henry J. Hyde United States Global Leadership Against
  HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, Public Law 108-25;
  Public Law 110-293. Title 42 [42 USC] U.S.C. &sect; Section 307 [42 USC 242l], as
  amended and Section 301(a) [42 USC 241(a)], as amended.
beneficiary_types:
- Anyone/general public
- Artist/Humanist
- Education Professional
- Federal
- Graduate Student
- Health Professional
- Individual/Family
- Interstate
- Local
- Minority group
- Other private institution/organization
- Private nonprofit institution/organization
- Profit organization
- Quasi-public nonprofit organization
- Scientist/Researchers
- Small business
- Specialized group (e.g. health professionals, students, veterans)
- Sponsored organization
- State
- Student/Trainee
- U.S. Territories
categories:
- Education - Health Education and Training
cfda: '93.494'
fiscal_year: '2022'
grants_url: https://grants.gov/search-grants?cfda=93.494
layout: program
objective: "CDC\u2019s global health priorities include efforts towards ending the\
  \ global tuberculosis (TB) epidemic by:  expanding access to improved screening,\
  \ contact tracing, and diagnostic tools to find the missing TB cases (FIND); optimizing\
  \ treatment for TB and multi-drug-resistant (MDR) TB, including identifying and\
  \ evaluating better treatment regimens, and expanding access to care and treatment\
  \ (CURE); breaking the cycle of TB transmission by strengthening infection control,\
  \ identifying TB hotspots to target screening, and scaling-up treatment to prevent\
  \ TB (PREVENT); and helping countries strengthen their surveillance and laboratory\
  \ systems, and workforce and research capacity to support sustainable health systems\
  \ including promoting the wider use and adoption of recommended TB strategies and\
  \ guidelines (SUSTAIN)."
obligations: '[{"x":"2022","sam_estimate":0.0,"sam_actual":750000.0,"usa_spending_actual":750000.0},{"x":"2023","sam_estimate":1724866.0,"sam_actual":0.0,"usa_spending_actual":955181.0},{"x":"2024","sam_estimate":3999999.0,"sam_actual":0.0,"usa_spending_actual":0.0}]'
permalink: /program/93.494.html
popular_name: ''
results: []
sam_url: https://sam.gov/fal/b7ea2e3a19c4468093a3b8f447fbaa13/view
sub-agency: Centers for Disease Control and Prevention
title: Global Tuberculosis:Developing,Evaluating,Implementing Evidence-based and Innovative
  Approaches to Find, Cure, and Prevent Tuberculosis Globally
usaspending_url: https://www.usaspending.gov/search/?hash=ccb94cf500f559a085865cea24062b84
---
